All changes for the tissue hematological system (287)

Identifier Name Type Tissues Organism Gene Data Actions
DAA608 Hodgkin's disease Pathological hematological system Human SeriesMorbidity
DAA610 Leukemia Pathological hematological system Human SeriesMorbidity
DAA609 Non-Hodgkin's lymphoma Pathological hematological system Human SeriesMorbidity
DAA935 Pro-B cell generation and differentiation declines Physiological bone marrow, B cell Human
DAA934 Number of mature B cells leaving the bone marrow declines Physiological bone marrow, B cell Human
DAA936 Volume of hematopoietic bone marrow decreases Physiological bone marrow Human
DAA1073 Fewer cells and higher apoptosis Physiological bone marrow Human
DAA2014 Microsatellite instability in hematopoietic stem cells and progenitor cells Physiological hematopoietic stem cells Human MLH1
DAA2035 Alterations in frequency, developmental potential and gene expression profile in hematopoietic stem cells Physiological hematopoietic stem cells Human
DAA673 telomere length in hematopoietic stem cells Molecular hematopoietic stem cells Human
DAA932 Renewal capacity declines Physiological hematopoietic stem cells Human
DAA2027 DNA damage acummulates in hematopoietic stem and progenitor cells Physiological hematopoietic stem cells Human
DAA1991 Hematopoietic cells accumulate random mutations Physiological hematopoietic stem cells Human
DAA2440 WNT1 inducible signaling pathway protein 2 precursor decreases with age Molecular mesenchymal stem cell Human WISP2 23.5% Decrease DNA Methylation
DAA678 Capacity of mesenchymal stem cells to differentiate into osteoblasts may be decreased Physiological mesenchymal stem cell Human
DAA2435 zinc finger protein 549 increases with age Molecular mesenchymal stem cell Human ZNF549 19.3% Increase DNA Methylation
DAA2442 ATP-binding cassette; sub-family A member 8 decreases with age Molecular mesenchymal stem cell Human ABCA8 25.0% Decrease DNA Methylation
DAA2433 cyclin-dependent kinase inhibitor 2B isoform 2 decreases with age Molecular mesenchymal stem cell Human CDKN2B 16.7% Decrease DNA Methylation
DAA2461 calcyphosine isoform b decreases with age Molecular mesenchymal stem cell Human CAPS 17.3% Decrease DNA Methylation
DAA2449 microfibrillar associated protein 5 decreases with age Molecular mesenchymal stem cell Human MFAP5 46.4% Decrease DNA Methylation
DAA2457 tumor necrosis factor receptor superfamily; member 17 increases with age Molecular mesenchymal stem cell Human TNFRSF17 18.8% Increase DNA Methylation
DAA2460 gelsolin-like capping protein decreases with age Molecular mesenchymal stem cell Human CAPG 19.3% Decrease DNA Methylation
DAA2444 AMP-activated protein kinase; non-catalytic gamma-3 subunit decreases with age Molecular mesenchymal stem cell Human PRKAG3 20.1% Decrease DNA Methylation
DAA2454 chemokine (C-C motif) receptor 1 increases with age Molecular mesenchymal stem cell Human CCR1 31.2% Increase DNA Methylation
DAA2013 Number and differentiation potential of adipose tissue-derived stem cells declines with age Physiological mesenchymal stem cell Human